Molnupiravir not to be included in COVID-19 clinical management protocol as of now

The experts cited safety concerns, arguing that Molnupiravir was not of much benefit in Covid treatment

Related Keywords

India ,United Kingdom ,New Delhi ,Delhi ,Balram Bhargava ,National Task ,Indian Council Of Medical Research ,Members Of The National Task ,Health Ministry ,Regulatory Agency ,Task Force ,Clinical Management Protocol ,Drug Regulator General ,National Task Force ,Medical Research ,United Kingdom Medicines ,Emergency Use Authorisation ,Molnupiravir ,Anti Viral Drug Molnupiravir ,Olnupiravir Covid Treatment ,Olnupiravir In Covid Treatment ,Olnupiravir Not Included In Covid Treatment ,Ovid Treatment Molnupiravir ,Molnupiravir Drug ,Olnupiravir Covid Drug ,Ovid Drug Molnupiravir ,